Publication Cover
Redox Report
Communications in Free Radical Research
Volume 8, 2003 - Issue 5
226
Views
15
CrossRef citations to date
0
Altmetric
Articles

Double-drug development against antioxidant enzymes from Plasmodium falciparum

, , &
Pages 280-283 | Published online: 19 Jul 2013

REFERENCES

  • Atamna H, Ginsburg H. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J Biol Chem 1995; 270: 24876–24883.
  • Ginsburg H, Famin O,Zhang J, Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 1998; 56: 1305–1313.
  • Schirmer RH, Muller JG, Krauth-Siegel RL. Disulfide reductase inhibitors as chemotherapeutic agents: the design of drugs for try-panosomiasis and malaria. Angew Chem Int Edn 1995; 34: 141–154.
  • Davioud-Charvet E, Delarue S, Biot C et al. A prodrug form of a Plasmodium fakiparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem 2001; 44: 4268–4276.
  • Meierjohann S, Walter RD, Muller S. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium fakiparum. Biochem J 2002; 368: 761–768.
  • Kanzok SM, Schirmer RH, Turbachova I, Iozef R, Becker K. The thioredoxin system of the malaria parasite Plasmodium fakiparum. Glutathione reduction revisited. J Biol Chem 2000; 275: 40180–40186.
  • Farber PM, Arscott LD, Williams Jr CH, Becker K, Schirmer RH. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett 1998; 422: 311–314.
  • Schonleben-Janas A, Kirsch P. Mittl PR, Schirmer RH, Krauth-Siegel RL. Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies. J Med Chem 1996; 39: 1549–1554.
  • Karplus PA, Pai EF, Schulz GE. A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution. Eur J Biochem 1989; 178: 693–703.
  • Salmon-Chemin L, Buisine E, Yardley V et al. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. J Med Chem 2001; 44: 548–565.
  • Delarue S, Girault S, Maes L et al. Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines. J Med Chem 2001; 44: 2827–2833.
  • Ginsburg H. A double-headed pro-drug that overcomes chloroquine resistance. Trends Parasitol 2002; 18:103.
  • Krnajski Z, Gilberger TW, Walter RD, Cowman AF, Muller S. Thioredoxin reductase is essential for the survival of Plasmodium fakiparum erythrocytic stages. J Biol Chem 2002; 277: 25970–25975.
  • Krauth-Siegel RL, Coombs GH. Enzymes of parasite thiol metabolism as drug targets. Parasitol Today 1999; 15: 404–409.
  • Dessolin J, Biot C, Davioud-Charvet E. Bromination studies of the 2,3-dimethylnaphthazarin core allowing easy access to naphthazarin derivatives. J Org Chem 2001; 66: 5616–5619.
  • Irmler A, Bechthold A, Davioud-Charvet E et al. Disulfide reductases - current developments. In: Chapman SK, Perham RN, Scrutton NS. (eds) Flavins and Flavoproteins 2002. Berlin: Agency for Scientific Publications, 2002; 803-815.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997; 46: 3–26.
  • Viswanadhan VN, Balan C, Hulme C, Cheetham JC, Sun Y. Knowledge-based approaches in the design and selection of compound libraries for drug discovery. Curr Opin Drug Discov Devel 2002; 5: 400–406.
  • Atamna H, Krugliak M, Shalmiev G, Deharo E, Pescarmona G, Ginsburg H. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochem Pharmacol 1996; 51: 693–700.
  • Biot C, Bauer H, Schirmer H, Davioud-Charvet E. Carboxylic acid surrogates and prodrugs of Plasmodium falciparum glutathione reductase inhibitors: Synthesis of 5-substituted tetrazoles, bioisosterism and mechanistic studies. Unpublished results.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.